Before revision:  Thus, our results suggest that these drugs could act against SARS-CoV-2 by altering the folding pathway of its receptor ACE2  .
After revision:  Thus, our results suggest that these drugs could act against SARS-CoV-2 by altering the folding pathway of its receptor ACE2 . Ongoing studies are directly evaluating the possibility of repurposing these drugs for the treatment of COVID-19 .